72
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Impacts of DRG-Based Prepayment Reform on the Cost and Quality of Patients with Neurologic Disorders: Evidence from a Quasi-Experimental Analysis in Beijing, China

ORCID Icon, , , &
Pages 1547-1560 | Received 12 Mar 2024, Accepted 10 May 2024, Published online: 11 Jun 2024

References

  • Bala MV, Zarkin GA. Application of cost-effectiveness analysis to multiple products: a practical guide. Am J Manag Care. 2002;8(3):211–218.
  • Iezzoni L. Risk Adjustment for Measuring Health Care Outcomes. 4th ed. Chicago: Health Administration Press; 2012.
  • Fetter RB, Shin Y, Freeman JL, Averill RF, Thompson JD. Case mix definition by diagnosis-related groups. Med Care. 1980;18(2 Suppl):iii–53.
  • Mathauer I, Wittenbecher F. Hospital payment systems based on diagnosis-related groups: experiences in low- and middle-income countries. Bull World Health Organ. 2013;91(10):746–756A. doi:10.2471/BLT.12.115931
  • Jian W, Lu M, Chan KY, et al. Payment reform pilot in Beijing hospitals reduced expenditures and out-of-pocket payments per admission. Health Aff. 2015;34(10):1745–1752. doi:10.1377/hlthaff.2015.0074
  • National Healthcare Security Administration. Notification of national pilot cities for DRG payment. Available from: http://www.nhsa.gov.cn/art/2019/6/5/art_37_1362.html. Accessed August 11, 2020.
  • Han YL. The mechanism and pathway of the health insurance payment reform from retrospective to prospective mode on the medical provider’s behavior. Chin J Health Policy. 2021;14(3):21–27.
  • Li CQ, Da T, K Z. Analysis of Impact of Payment Methods on Medical Quality. Chin Health Econ. 2011;30:63.
  • Leu A, Wepf H, Elger B, Wangmo T. Experts’ perspectives on SwissDRG: second class care for vulnerable patient groups? Health Policy. 2018;122(6):577–582. doi:10.1016/j.healthpol.2018.03.001
  • Koné I, Maria Zimmermann B, Nordström K, Simone Elger B, Wangmo T. A scoping review of empirical evidence on the impacts of the DRG introduction in Germany and Switzerland. Int J Health Plann Manage. 2019;34(1):56–70. doi:10.1002/hpm.2669
  • Ndayishimiye C, Tambor M, Dubas-Jakóbczyk K. Barriers, and facilitators to healthcare provider payment reform - A scoping literature review. Risk Manag Health Policy. 2023;16:1755–1779. doi:10.2147/RMHP.S420529
  • Zou K, Li HY, Zhou D, Liao ZJ. The effects of diagnosis-related groups payment on hospital healthcare in China: a systematic review. BMC Health Serv Res. 2020;20(1):112. doi:10.1186/s12913-020-4957-5
  • Barber SL, Borowitz M, Bekedam H, Ma J. The hospital of the future in China: china’s reform of public hospitals and trends from industrialized countries. Health Policy Plan. 2014;29(3):367–378. doi:10.1093/heal/czt023
  • Xu J, Jian W, Zhu K, Kwon S, Fang H. Reforming public hospital financing in China: progress and challenges. BMJ. 2019;365:l4015. doi:10.1136/bmj
  • Zhang Y, Fu J, Yuan Z, et al. The role of cell senescence in the occurrence and development of neurological diseases. Chin Med Univ J. 2023;52(09):847–851.
  • Bureau of Statistics National and Bureau of Statistics Beijing Survey Team. Beijing’s 2022 national economic and social development statistical bulletin; 2023:12.
  • Deng XH. Development, application, and promotion of DRGs in China. Chin J Hosp Adm. 2015;31(11):809–812.
  • Bureau of Medical Insurance and Maternity Insurance. Key indicators of health insurance and maternity insurance for the semi-annual period of 2023; 2023.
  • Zhang T, Lu B, Song Y, Chen M. Impacts of outpatient payment reforms on volume and expenditures in public hospitals: evidence from a quasi-experimental analysis in Zhejiang, China. Risk Manag Health Policy. 2023;16:415–424. doi:10.2147/RMHP.S400385
  • Qian M, Zhang X, Chen Y, Xu S, Ying X. The pilot of a new patient classification-based payment system in China: the impact on costs, length of stay and quality. Soc Sci Med. 2021;289:114415. doi:10.1016/j.socscimed.2021.114415
  • Wei A, Ren J, Feng W. The impact of DRG on resource consumption of inpatient with ischemic stroke. Front Public Health. 2023;11:1213931. doi:10.3389/fpubh.2023.1213931
  • Zhang T, Lu B, Yan Z, Huang X, Lu W. Impacts of a new episode-based payment scheme on volume, expenditures, and efficiency in public hospitals: a quasi-experimental interrupted time-series study in Jinhua, China. Risk Manag Health Policy. 2022;15:1659–1669. doi:10.2147/RMHP.S376516
  • Zhang L, Sun L. Impacts of diagnosis-related groups payment on the healthcare providers’ behavior in china: a cross-sectional study among physicians. Risk Manag Health Policy. 2021;14:2263–2276. doi:10.2147/RMHP.S308183
  • Cook A, Averett S. Do hospitals respond to changing incentive structures? Evidence from Medicare’s 2007 DRG restructuring. J Health Econ. 2020;73:102319. doi:10.1016/j.jhealeco.2020.102319
  • Quentin W, Scheller-Kreinsen D, Blümel M, Geissler A, Busse R. Hospital payment based on diagnosis-related groups differs in Europe and holds lessons for the United States. Health Aff. 2013;32(4):713–723. doi:10.1377/hlthaff.2012.0876